Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce cardiovascular and respiratory events in patients hospitalized with COVID-19, as well as to evaluate the efficacy and safety of CardiolRx in acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada. Show More...
-
Website https://www.cardiolrx.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 1.71 CAD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2009-12 2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 TTM Earnings Per Share CAD -0.07 -1.03 -0.76 Dividends CAD Payout Ratio % * Shares Mil 23.0 15.0 26.0 Book Value Per Share * CAD -0.14 0.51 Free Cash Flow Per Share * CAD -0.13 Return on Assets % -51.57 -113.91 -125.48 Financial Leverage (Average) 1.13 1.11 1.1 Return on Equity % -58.2 -126.5 -293.21 Return on Invested Capital % -54.77 -125.04 -152.03 Interest Coverage Current Ratio 14.06 11.22 11.39 Quick Ratio 13.91 8.03 7.08 Debt/Equity 0.07 0.010 0.010